News Sentiment

REGN sentiment intelligence

Regeneron Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 60 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 664.52 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 53

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend inactive

+1.6% over one week, +8.6% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Regeneron Pharmaceuticals (REGN) Stumbled In A Trial Setback, Is The Stock Still Cheap?

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction 1.6% Price digesting
Trend fit Trend inactive 8.6% over four weeks
Fair value -14.7% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 26
Negative 15

Relevance

Why the article matched

Direct first
Direct company coverage 53
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Market source 18
simplywall.st 6
Simply Wall Street 4
GuruFocus 4
Ad Hoc News 3
Moomoo 3
MarketWatch 2
Stocktwits 2

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 15
Analyst action 10
Deals and strategy 3
Regulatory and legal 2
Guidance 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 60